26-A-16654-ACC REDUCED RISK OF SINUS NODE DYSFUNCTION WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: EVIDENCE FROM A SYSTEMATIC REVIEW OF CLINICAL TRIALS